Movano Health Granted Glucose and Blood Pressure Monitoring Patents

Movano Health's SoC combines multiple antennas and a variety of frequencies in the smallest ever RF-enabled integrated circuit.

Evie 3x Rings Shadow
Movano Health

Movano Health, makers of the Evie Ring, has been granted three new patents (2 U.S.; 1 China) further safeguarding the company's systems and methods for radio frequency-enabled health monitoring with specific protection for health parameters of blood glucose levels, blood pressure and heart rate. These new patents extend Movano Health's growing IP portfolio to 21 patents issued and 38 pending.  Of note is US Pat No. 11,583,199, a foundational patent that enables Movano Health to measure health metrics using amplitude or phase information from its proprietary System-on-a-Chip (SoC).

"We are committed to elevating the standards of wearable health technology and aim to create more accurate, flexible and cost-effective wearable solutions that monitor health metrics, including glucose and blood pressure, non-invasively and without a cuff," said John Mastrototaro, CEO of Movano Health. "To do so, we're taking a different approach than our predecessors in the wearable space. Rather than using optical sensors, we've made a significant investment in developing a proprietary RF-enabled SoC. Our SoC gives us the opportunity for increased accuracy, is more compact, allowing us to build smaller devices and the materials are more cost-effective. These new patents are a crucial component of protecting our investment in RF and our SoC, and they are helping us emerge as a leader in RF within the health space."

Movano Health's SoC combines multiple antennas and a variety of frequencies in the smallest ever RF-enabled integrated circuit (IC) designed specifically for blood pressure or glucose monitoring systems. Movano Health has spent more than five years building this novel sensor technology from the ground up in an effort to achieve an unprecedented level of precision in health monitoring. The SoC is being integrated into Movano Health's smallest wrist worn wearable to date and will be tested in clinical studies in March 2023. After further testing, the Company plans to incorporate the SoC into its wearable devices in the future.

The new patents include:

  • US Pat. No. 11,583,199 (systems for health monitoring using radio waves that include mixing signals at different frequencies): This core patent covers an RF-based health monitoring device that includes signal processing circuits specifically designed to improve RF-based health monitoring.
  • US Pat. No. 11,576,586 (methods for radio wave-based health monitoring that utilize data derived from amplitude and/or phase data): This patent covers methods for health monitoring that include signal processing techniques specifically designed to improve RF-based health monitoring.
  • Chinese Pat. No.: ZL201980084505.1 (methods and systems for multi-band radar-based sensing): This patent covers Movano Health's RF multi-band chip and represents the Company's continuing effort to secure IP protection for its novel RF chip architecture in key foreign jurisdictions.